SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 286.43 |
| Enterprise Value ($M) | 273.59 |
| Book Value ($M) | 85.10 |
| Book Value / Share | 1.43 |
| Price / Book | 3.37 |
| NCAV ($M) | 84.50 |
| NCAV / Share | 1.42 |
| Price / NCAV | 3.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.44 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.80 |
| Current Ratio | 6.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 116.72 |
| Assets | 117.32 |
| Liabilities | 32.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 15.60 | 7.94 | |
| 13G | Vanguard Group Inc | 6.68 | ||
| 13G | BlackRock, Inc. | 5.80 | 251.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 130,939 | 585,640 | 22.36 | |
| 68,317 | 347,956 | 19.63 | |
| 142,541 | 551,313 | 25.85 | |
| 121,161 | 633,345 | 19.13 | |
| 319,006 | 1,894,557 | 16.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKAN – Akanda Corp. | AKBA – Akebia Therapeutics, Inc. |
| ALBT – Avalon GloboCare Corp. | ALGS – Aligos Therapeutics, Inc. |
| ALRN – Aileron Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io